New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
13:03 EDTHZNPHorizon Pharma shares offer 'significant value,' says Stifel
Stifel sees "significant value" in shares of Horizon Pharma with today's pullback and it keeps a Buy rating on the name. The firm says Express Scripts and Caremark putting Duexis and Vimovo on their exclusion lists is a "large disappointment," but it believes management has several avenues to offset the impact. Stifel lowered its price target for shares to $20 from $25.
News For HZNP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 21, 2015
10:01 EDTHZNPOn the Fly: Analyst Initiation Summary
Subscribe for More Information
06:08 EDTHZNPHorizon Pharma initiated with a Buy at Citigroup
Subscribe for More Information
January 15, 2015
10:00 EDTHZNPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:14 EDTHZNPHorizon Pharma initiated with a Buy at UBS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use